News Sanofi buys Provention and diabetes drug Tzield for $2.9bn T1D prevention drug has been tipped as a blockbuster, boosting Sanofi's diabetes franchise.
News Carl Icahn planning proxy fight at Illumina; report Activist investor claims takeover of liquid biopsy firm Grail points to "reckless" management.
News Money held by SVB UK clients safe, thanks to HSBC HSBC steps forward to take over SVB's UK customers, protecting their deposits.
News Sandoz bolsters biosimilars with $400m Slovenia plant New facility will be based at Sandoz' Lek subsidiary, and employ 300 staff when completed.
News Gilead gets big $175m judgment in HIV fraud case Massive judgment takes the total awarded to the pharma company to nearly $250 million.
News Pfizer’s Susan Rienow named new president of ABPI Appointment follows the exit of Novo Nordisk's Pinder Sahota, after firm's ABPI code breaches.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
